DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462,336 | -74.5% | 51,600 | -67.9% | 0.00% | -80.0% |
| Q2 2023 | $1,810,125 | -33.6% | 160,900 | -32.0% | 0.01% | -28.6% |
| Q1 2023 | $2,724,480 | +119.1% | 236,500 | +120.4% | 0.01% | +133.3% |
| Q4 2022 | $1,243,607 | +144.8% | 107,300 | +168.2% | 0.00% | +200.0% |
| Q3 2022 | $508,000 | +204.2% | 40,000 | +64.6% | 0.00% | – |
| Q2 2022 | $167,000 | -64.3% | 24,300 | -49.9% | 0.00% | -100.0% |
| Q1 2022 | $468,000 | -21.1% | 48,500 | -2.8% | 0.00% | 0.0% |
| Q4 2021 | $593,000 | +33.3% | 49,900 | +82.1% | 0.00% | 0.0% |
| Q3 2021 | $445,000 | -18.3% | 27,400 | +5.8% | 0.00% | 0.0% |
| Q2 2021 | $545,000 | -3.4% | 25,900 | -28.7% | 0.00% | -50.0% |
| Q1 2021 | $564,000 | +10.2% | 36,300 | +48.8% | 0.00% | +100.0% |
| Q4 2020 | $512,000 | – | 24,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |